Article

Design and optimization of a novel reverse transcription linear-after-the-exponential PCR for the detection of foot-and-mouth disease virus.

Department of Biology, Brandeis University, Waltham, MA 02454, USA.
Journal of Applied Microbiology (Impact Factor: 2.39). 11/2009; 109(1):180-9. DOI: 10.1111/j.1365-2672.2009.04640.x
Source: PubMed

ABSTRACT A novel molecular assay for the detection of foot-and-mouth disease virus (FMDV) was developed using linear-after-the-exponential polymerase chain reaction (LATE-PCR).
Pilot experiments using synthetic DNA targets demonstrated the ability of LATE-PCR to quantify initial target concentration through endpoint detection. A two-step protocol involving reverse transcription (RT) followed by LATE-PCR was then used to confirm the ability of the assay to detect FMDV RNA. Finally, RT and LATE-PCR were combined in a one-step duplex assay for co-amplification of an FMDV RNA segment and an internal control comprised of an Armored RNA. In that form, each of the excess primers in the reaction mixture hybridize to their respective RNA targets during a short pre-incubation, then generate cDNA strands during a 3-min RT step at 60°C, and the resulting cDNA is amplified by LATE-PCR without intervening sample processing.
The RT-LATE-PCR assay generates fluorescent signals at endpoint that are proportional to the starting number of RNA targets and can detect a range of sequence variants using a single mismatch-tolerant probe.
In addition to offering improvements over current laboratory-based molecular diagnostic assays for FMDV, this new assay is compatible with a novel portable ('point-of-care') device, the BioSeeq II, designed for the rapid diagnosis of FMD in the field.

Download full-text

Full-text

Available from: Lawrence Wangh, Jul 06, 2015
0 Followers
 · 
125 Views
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: AIMS: The goal of this study was to develop a molecular diagnostic multiplex assay for the quantitative detection of microbial pathogens commonly responsible for Ventilator- Associated Pneumonia (VAP) and their antibiotic resistance using Linear-After-The-Exponential Polymerase Chain Reactions (LATE-PCR). METHOD AND RESULTS: This multiplex assay was designed for quantitative detection and identification of pathogen genomic DNA of Methicillin Resistant Staphylococcus aureus (MRSA), Acinetobacter baumannii, Pseudomonas aeruginosa, plus a control target from Lactococcus lactis. After amplification, the single-stranded amplicons were detected simultaneously in the same closed tube by hybridization to low temperature molecular beacon probes labeled with four differently colored fluorophores. The resulting hybrids were then analyzed by determining the fluorescence intensity of each of the four fluorophores as a function of temperature. CONCLUSIONS: This LATE-PCR single tube multiplex assay generated end-point fluorescent contours that allowed identification of all microbial pathogens commonly responsible for VAP, including MRSA. The assay was quantitative, identifying the pathogens present in the sample, no matter whether there were as few a 10 or as many 100,000 target genomes. SIGNIFICANCE AND IMPACT OF THE STUDY: This assay is rapid, reliable, and sensitive and is ready for preclinical testing using samples recovered from patients suffering from Ventilator-Associated Pneumonia. This article is protected by copyright. All rights reserved.
    Journal of Applied Microbiology 06/2013; DOI:10.1111/jam.12281 · 2.39 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aims: To verify monoplex and multiplex gene-specific linear-after-the-exponential polymerase chain reaction (LATE-PCR) assays for identifying 17 microbial pathogens (i.e., Klebsiella sp., Acinetobacter baumannii, Staphylococcus aureus, Enterobacter sp., Pseudomonas aeruginosa, coagulase negative staphylococci, Enterococcus sp., Candida sp.) commonly associated with septica-emia using clinical isolates. Methods and Results: Clinical isolates of each target pathogen were collected from the University of California, Davis Medical Center (UCDMC) microbiology laboratory. Five microlitres (ll) of each culture suspension (1 9 10 8 CFU ml À1) were added to 20 ll of monoplex mastermix. DNA extracted from clinical isolates was tested in multiplex. Monoplex assays demonstrated 100% sensitivity at this input level, except Enterobacter cloacae (2Á7%), Ac. baumannii (57%) and Ps. aeruginosa (97Á8%). All clinical isolates were positive in multiplex, with the exception of two Ac. baumannii, two Klebsiella oxytoca and two Candida parapsilosis isolates. Conclusions: Sixteen pathogens can be identified by monoplex LATE-PCR assays with sensitivities ! 97Á8%. The multiplex assay demonstrated 91Á4% sensitivity when tested with DNA extracted from 70 different target strains. Significance and Impact of the Study: This study demonstrates the potential of LATE-PCR to serve as an adjunct to culture if the reagents are optimized for sensitivity. Results warrant further testing through analytical and clinical validation of the multiplex assay.
    Journal of Applied Microbiology 02/2013; 114(2). DOI:10.1111/jam.12062 · 2.39 Impact Factor